The global artificial saliva market is gaining rapid momentum as the number of people suffering from xerostomia (dry mouth) continues to rise due to chronic conditions, medication use, and aging-related health issues. Valued at USD 1.56 Billion in 2025, the market is projected to reach USD 3.94 Billion by 2035, expanding at a robust CAGR of 9.70%. This growth reflects increasing awareness of oral health, advancements in synthetic saliva formulations, and growing demand across clinical and home-care settings.

Introduction: Artificial Saliva Becomes a Critical Solution for Dry Mouth Management

Xerostomia affects millions worldwide and is often linked to conditions such as diabetes, Sjögren’s syndrome, cancer therapies, and long-term medication use. For many patients, natural saliva production becomes insufficient, leading to difficulty in speaking, swallowing, tasting, and maintaining oral hygiene. Artificial saliva products—available as sprays, gels, rinses, or lozenges—help restore moisture, improve comfort, and reduce the risk of oral infections.

As the global population ages and chronic disease prevalence continues to rise, artificial saliva is becoming an essential therapeutic solution, not just a supplementary product.

Detailed Market Analysis

1. Rising Prevalence of Xerostomia Drives Demand

A growing number of individuals experience dry mouth due to polypharmacy, cancer radiotherapy, autoimmune disorders, and lifestyle factors. This demand directly fuels the adoption of artificial saliva products.

2. Enhanced Formulations Improve Market Adoption

Manufacturers are developing advanced, long-lasting formulations that better mimic natural saliva through electrolyte blends, enzymes, and moisturizing polymers. These improvements are increasing product preference among patients and clinicians.

3. Expanding Use in Elderly Population

The senior demographic represents one of the largest consumer groups due to age-related decline in salivary gland function. With global aging accelerating, this segment significantly contributes to market growth.

4. Growth of Online Pharmacies and Home-Care Solutions

E-commerce platforms and home-use healthcare products have boosted accessibility to artificial saliva, increasing consumer convenience and widening market reach.

5. Increasing Awareness of Oral Health

Public awareness campaigns, dental care programs, and healthcare recommendations are prompting more patients to seek early treatment for dry mouth symptoms.

Access a free sample report with a comprehensive table of contents included.

Key Market Players

Livealth Biopharma Pvt Ltd

GlaxoSmithKline Plc

Fresenius Kabi AG

Honeywell International, Inc.

Parnell Pharmaceuticals, Inc.

Forward Science

Biocosmetics Laboratories

Bausch Health

These companies are actively investing in improved formulations, expanded distribution channels, and patient-comfort-focused innovations.